TY - JOUR
T1 - Executive function predict the quality of life and negative emotion in older adults with diabetes
T2 - A longitudinal study
AU - Ho, Hsiao Ting
AU - Lin, Sang I.
AU - Guo, Nai Wen
AU - Yang, Yi Ching
AU - Lin, Ming Hsing
AU - Wang, Chong Shan
N1 - Funding Information:
This study was supported by the National Health Research Institute, Taiwan (NHRI-EXT-103-10302PI) and funding from the Headquarters of University Advancement at the National Cheng Kung University, which was sponsored by the Ministry of Education, Taiwan. The authors thank Meng-Yu Chen, Chia-Chun Tsou, Pei-Yin Hsieh, Ya-Ting Yin and Chien-Yi Pao their help. This study was approved by the institutional review board of National Cheng Kung University Hospital. All participants signed the informed consent.
Funding Information:
This study was supported by the National Health Research Institute , Taiwan ( NHRI-EXT-103-10302PI ) and funding from the Headquarters of University Advancement at the National Cheng Kung University , which was sponsored by the Ministry of Education , Taiwan. The authors thank Meng-Yu Chen, Chia-Chun Tsou, Pei-Yin Hsieh, Ya-Ting Yin and Chien-Yi Pao their help.
Publisher Copyright:
© 2022 Primary Care Diabetes Europe
PY - 2022
Y1 - 2022
N2 - Aims: To investigate the influence of executive function (EF) on current and future quality of life (QoL) and negative emotion (NE) in older adults with diabetes. Methods: A total of 128 older adults with diabetes were recruited. Independent variables (demographic information, health and medical conditions, cognitive function, life function) were collected in the first year. Dependent variables (QoL and NE) were collected for 3 years. Pearson's correlation coefficient analysis and stepwise multiple linear regression analysis were performed to identify the predictors of QoL and NE. Results: EF was the strongest predictor for overall QoL and NE in all 3 years, and accounted for 23.0–36.2% and 11.1–17.1% of the variance, respectively. The second strongest predictor for overall QoL in all 3 years was pain interference, which accounted for 3.2–5.8% of the variance. Pain interference was also the second strongest predictor for NE in the second year, accounting for 5.5% of the variance. Conclusions: The present study revealed that EF is more predictive than pain for current and future QoL and NE in older adults with diabetes. We recommend that EF be included as an indicator for diabetes surveillance, and that prevention of EF decline be a part of diabetes management plans.
AB - Aims: To investigate the influence of executive function (EF) on current and future quality of life (QoL) and negative emotion (NE) in older adults with diabetes. Methods: A total of 128 older adults with diabetes were recruited. Independent variables (demographic information, health and medical conditions, cognitive function, life function) were collected in the first year. Dependent variables (QoL and NE) were collected for 3 years. Pearson's correlation coefficient analysis and stepwise multiple linear regression analysis were performed to identify the predictors of QoL and NE. Results: EF was the strongest predictor for overall QoL and NE in all 3 years, and accounted for 23.0–36.2% and 11.1–17.1% of the variance, respectively. The second strongest predictor for overall QoL in all 3 years was pain interference, which accounted for 3.2–5.8% of the variance. Pain interference was also the second strongest predictor for NE in the second year, accounting for 5.5% of the variance. Conclusions: The present study revealed that EF is more predictive than pain for current and future QoL and NE in older adults with diabetes. We recommend that EF be included as an indicator for diabetes surveillance, and that prevention of EF decline be a part of diabetes management plans.
UR - http://www.scopus.com/inward/record.url?scp=85132392815&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132392815&partnerID=8YFLogxK
U2 - 10.1016/j.pcd.2022.05.002
DO - 10.1016/j.pcd.2022.05.002
M3 - Article
C2 - 35659729
AN - SCOPUS:85132392815
SN - 1751-9918
VL - 16
SP - 537
EP - 542
JO - Primary Care Diabetes
JF - Primary Care Diabetes
IS - 4
ER -
